TrialMedicine2020

Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study.

Qiufen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.